Philips Respironics Trilogy Evo O2 Ventilator Recall

FDA issued a Class I recall (Z-1615-2026) for Philips Respironics Trilogy Evo O2 continuous home-use ventilators due to a critical malfunction. Using non-pneumatic nebulizers with these devices may cause discrepancies between the set tidal volume and the tidal volume actually delivered to patients, posing serious safety risks. The recall affects devices with Software Version 1.05.15.00 distributed both nationally in the US and internationally.

FERC Gas Pipeline Orders - Tariff Acceptances, Waivers, and Project Approvals

The Federal Energy Regulatory Commission issued 50 gas pipeline orders between April 1-6, 2026, covering tariff acceptances, rate adjustments, project approvals, and waiver grants for various natural gas pipeline operators including Black Hills/Kansas Gas Utility, Alliance Pipeline, Transcontinental Gas Pipe Line, and East Tennessee Natural Gas.

Merit Medical ProGuide Chronic Dialysis Catheter Recall - Hemorrhage Risk

FDA issued a Class I recall for Merit Medical Systems ProGuide Chronic Dialysis Catheters due to a design defect in the 16F dual-valved splittable sheath introducer that may not split as intended. The defect can result in hemorrhage, foreign bodies left in patients, and procedure delays. 847 units distributed nationwide across multiple states.

Erbe USA Cryoprobe Recall - Rupture Risk

FDA issued a Class I recall for Erbe USA Inc's Flexible Cryoprobe (REF: 20402-411) due to risk of rupture or burst during activation. The recall affects devices distributed nationwide across the US and Puerto Rico. Healthcare providers must immediately cease use of affected devices and return them to the manufacturer.

Merit Medical CentrosFLO Hemodialysis Catheter Recall - Design Defect

FDA issued a Class I recall for Merit Medical CentrosFLO Hemodialysis Catheters due to a design defect in the 16F dual-valved splittable sheath introducer that may not split as intended. The defect may result in hemorrhage, foreign bodies remaining in the patient, and procedure delays. The recall affects multiple product codes and models distributed nationwide across at least 22 states.

Erbe Cryoprobe Recall - Rupture Risk

FDA issued a Class I recall for Erbe USA Inc. Flexible Cryoprobe (REF: 20402-401) due to risk of rupture or burst during device activation. The recall (Z-1566-2026) affects products distributed nationwide in the US including Puerto Rico. Class I is the most serious recall classification, indicating reasonable probability of serious adverse health consequences or death.

Philips Trilogy EV300 Recall - Tidal Volume Discrepancy Risk

The FDA issued a Class I recall (Z-1616-2026) for Philips Respironics Trilogy EV300 ventilators running Software Version 1.05.15.00 due to tidal volume discrepancies when non-pneumatic nebulizers are used. The recall affects devices distributed both domestically and internationally. Philips is notifying customers of the safety issue and providing guidance on mitigating the risk.

Daily Summary Index - 85 Official Publications

The Spanish Official Gazette (BOE) published its daily summary for April 7, 2026, containing 85 documents across multiple sections including general provisions, personnel matters, other dispositions, and public procurement. Key departments include Banco de España, AEPD (data protection), CNMC (competition), and regional autonomous communities.

Simplified Municipal Telecommunications Tax Rates

The Illinois Department of Revenue issued bulletin FY 2026-19 informing telecommunications service providers of new Simplified Municipal Telecommunications Tax rates effective July 1, 2026. Carlyle's combined rate increases from 8.65% to 13.65%, while Danvers' combined rate increases from 8.65% to 14.65%. The state rate remains fixed at 8.65% with local additions of up to 6.00%.

UK FCA Annual Work Programme 2026/27

The UK FCA published its annual work programme for 2026/27, outlining four strategic priorities: becoming a smarter regulator through AI, supporting growth, helping consumers, and tackling financial crime. Key planned activities include regulating deferred payment credit (BNPL) from July 2026 and developing AI-enabled authorisation tools. The programme covers capital requirements reform for investment firms, a bonds consolidated tape, and T+1 settlement cycle adoption.